共 106 条
[1]
de Lima M(2014)Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation Biol Blood Marrow Transpl 20 4-13
[2]
Avigan D(2013)Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies Biol Blood Marrow Transpl 19 1661-1669
[3]
Collin M(2018)Human dendritic cell subsets: an update Immunology 154 3-20
[4]
Bigley V(2019)Are conventional type 1 dendritic cells critical for protective antitumor immunity and how? Front Immunol 10 9-3017
[5]
Cancel JC(2012)Plasmacytoid dendritic cells control T-cell response to chronic viral infection Proc Natl Acad Sci USA 109 3012-966
[6]
Crozat K(2010)Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual Immunity 33 955-1175
[7]
Dalod M(2008)Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice J Clin Invest 118 1165-1320
[8]
Mattiuz R(2017)In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells Cancer Immunol Immunother 66 1307-1337
[9]
Cervantes-Barragan L(2015)Robust anti-viral immunity requires multiple distinct T Cell-dendritic cell interactions Cell 162 1322-647
[10]
Swiecki M(2018)CD4(+) T cell help in cancer immunology and immunotherapy Nat Rev Immunol 18 635-1436